SLIDE TITLE Presented by. SLIDE TITLE Presented by.

Slides:



Advertisements
Similar presentations
Innovations in Structured Products October 25, 2010 An Innovator’s Dilemma?
Advertisements

USING EFIC TO FUND YOUR NEXT CONTRACT 12 February 2015.
Martin Arnold Director - Research Analyst ETF Securities.
STRICTLY CONFIDENTIAL Positioning for Growth Tasmanian Strata Industry Tim MacKenzie Associate Director Friday 9 th August.
The Demand and Supply of High Quality Liquid Collateral Post Financial Crisis Discussion at PBOC/Tsinghua Global Finance Forum The views expressed in this.
Managing HFAs’ Financial Health in the Face of Uncertainty NCSHA Annual Conference October 21, 2014 Ping Hsieh, Vice President – Senior Analyst.
Client Update September 2013 Andrew Tasker – GFM Representative WA.
Anticipated 2008 Generic Launches JULY 2008 David Harding, API Intelligence, Thomson Reuters Source: FDA, NEWPORT HORIZON PREMIUM TM © THOMSON REUTERS.
Copyright 2011, Atmel December, 2011 Atmel ARM-based Flash Microcontrollers 1 1.
MESSAGING IN THE MEDIA TOP 10 DRUGS BASED ON CREDIBILITY INDEX IN THE LITERATURE JOHN KNAPP, DIRECTOR OF ANALYTICS MAY 2009 Your use of these materials.
Therapeutic area breakdown of lead projects in development for first launch in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM ©
Paragraph IV Patent Challenges – As of July 1, 2008 JULY 2008 David Harding, API Intelligence, Thomson Reuters Source: FDA, NEWPORT HORIZON PREMIUM TM.
Despec Computer Inc. 11 August 2014 İstanbul Analyst Presentation nd Quarter – Financial & Operational Results.
Proportion of biotech-derived active substances in development for first launch 31st December APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.
Title Goes Here; 2 Lines Maximum; Choose from 1 of the 3 Title Slides Author(s): Firstname, Last name, Degree(s) Academic Affiliation : Institution, Title.
Leadership, Knowledge, Solutions…Worldwide. State of the Market Update D&O Liability Insurance Andrea Orviss, Vancouver November 4, 2010.
Place Client Logo Here Oil Market Outlook Paul Horsnell Head of Commodities Research, Barclays Capital Intertanko Singapore Tanker Event 30 March 2006.
Proportion of total R&D expenditure by therapeutic area in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS Your.
Global R&D expenditure, development times, global pharmaceutical sales and new molecular entity output MARCH 2008 SOURCE: CMR INTERNATIONAL.
2005/2006 Expenditure on biotech derived entities had remained constant APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS.
Number of pharmaceutical patent applications and granted patents for 5 major patent issuing authorities JUNE 2008 SOURCE: DERWENT WORLD PATENTS.
Sustainability Case Studies. Activity 3: Sustainability Case Studies LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers.
Regulatory approval times between submission and marketing authorization approval APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM.
Availability of High-Quality API for India, China and Rest of World MARCH 2008 David Harding, API Intelligence, Thomson Reuters Source: NEWPORT HORIZON.
Allocation of R&D expenditure in 2005 between chemical entity and biological or biotech active substances APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.
Ideas about Evolution. Activity 14: Ideas about Evolution LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers currently.
The economic outlook. 2 Greece Russia 3 The deflation-ghost.
The secure site rendering issue (all navigation crushed together as a list at the top of the page) is a compatibility issue with Internet Explorer only.
Genes and Traits. Activity 5: Genes and Traits LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers currently teaching.
E&O Considerations for Coastal Agencies Exposures & Risk Management Corporate Solutions.
Colin George 30 March 2016 Export Finance for SMEs.
To us there are no foreign markets. ™ Understanding Your Employee Stock Option Plan June 2014 To us there are no foreign markets. ™
01 Autofacts 2011 Q1 Autofacts ® SWOT analysis Alliance Group ? 200? Q?
Indeks Computer Inc nd Quarter – Financial & Operational Results Analyst Presentation 19 August 2014 İstanbul.
HRMS At India Infoline 2008.
RaboDirect Financial Health Barometer 2016
Mountain Plains Housing Summit 2016
BIOLOGY / CHEMISTRY CITATIONS GROWTH
Enter Presentation Title
Protect your Business April 2018
Messaging in the Media TOP 10 AUDIENCES BY THERAPY AREA
The Demand and Supply of High Quality Liquid Collateral Post Financial Crisis Discussion at PBOC/Tsinghua Global Finance Forum by Jian Hu, Managing Director,
2006 Revenue continued to depend on a relatively small number of products APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS.
, R&D expenditure showed 6% growth annually
2002–2006 Mid and Other sized companies continued to launch the majority of NMEs APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON.
Proportion of total R&D expenditure on alliances or joint ventures by stage of R&D in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM.
Market linked debentures
PROPER COMPLIANCE AND COMPELLING MARKETING 21ST APRIL 2017
% of the projects in development in the leading therapeutic areas were considered to have a novel mode of action APRIL 2007 SOURCE: CMR INTERNATIONAL.
Enter Presentation Title
Pipeline size of Major companies had grown at a steadier rate than that of smaller companies APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.
Development time for new molecular entities first launched onto the world market between MARCH 2008 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS.
Cycle times decreased in larger but not smaller, companies
Heading. Heading GLACIER FINANCIAL SOLUTIONS (PTY) LTD IS A LICENSED FINANCIAL SERVICES PROVIDER. Any information contained in this presentation.
AGENDA – Date Heading.
SLIDE TITLE Presented by. SLIDE TITLE Presented by.
One relationship. Many resources for business owners.
SLIDE TITLE Presented by. SLIDE TITLE Presented by.
Heading Presented by. heading Presented by AGENDA.
GLACIER FINANCIAL SOLUTIONS (PTY) LTD IS A LICENSED FINANCIAL SERVICES PROVIDER. Any information contained in this presentation as well as.
AGENDA – Date. AGENDA – Date Heading.
Nimbus fixed option by Presented by. Nimbus fixed option by Presented by.
Heading. Heading AGENDA – Date.
AGENDA.
SLIDE TITLE Presented by. SLIDE TITLE Presented by.
SLIDE TITLE Presented by. SLIDE TITLE Presented by.
Nimbus fixed option by Presented by. Nimbus fixed option by Presented by.
Oxford Village Tenancy Plan Paul Trachtenberg
AGENDA. AGENDA SLIDE TITLE Presented by.
Financial Performance Report
Presentation transcript:

SLIDE TITLE Presented by

AGENDA

SUMMARY Glacier Financial Solutions (Pty) Ltd is a Licensed Financial Services Provider.

GLACIER INTERNATIONAL IS A DIVISION OF SANLAM LIFE INSURANCE LIMITED LTD. The information in this presentation is provided for information purposes only and should not be construed as the rendering of advice to clients. Although we have taken reasonable steps to ensure the accuracy of the information, neither Sanlam nor any of its subsidiaries accept any liability whatsoever for any direct, indirect or consequential loss arising from the use of, or reliance in any manner on the information provided in this document. A member of the Sanlam Group Private Bag X5, Tyger Valley 7536 Email: clientservices@glacierinternational.co.za Tel +27 (0)21 917 9333 www.glacierinternational.com Reg No 1998/021121/06 Licensed Financial Services Provider